This site is intended for healthcare professionals
FDA Navigation
  • Home
  • /
  • Drugs
  • /
  • N
  • /
  • Nitrofurantoin (monohydrate/macrocrystals)
FDA Drug information

Nitrofurantoin (monohydrate/macrocrystals)

Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)

Learning Zones

Alopecia areata learning zone
Learning Zone Homepage
Alopecia areata Learning Zone
60 mins
Type 2 Diabetes Learning Zone teaser tile
Learning Zone Homepage
Weight control in type 2 diabetes
60 mins
Responding to unmet needs for metastatic castration-resistant prostate cancer
Learning Zone homepage
Metastatic castration-resistant prostate cancer Learning Zone
70 mins
Multiple Sclerosis Resources
Learning Zone Homepage
Multiple Sclerosis Resources
100 mins
Myocardium Cardiac muscle fibers banner image
Learning Zone Homepage
Pompe Disease: Key findings from WMS 2022
80 mins
Biomarker innovation in Alzheimer’s disease Learning Zone
Learning Zone Homepage
Biomarker innovation in Alzheimer’s disease Learning Zone
60 mins
Doctor holding patient
Learning Zone Homepage
Supportive care in oncology Learning Zone
150 mins
Green eye biosimilars retinal disease teaser tile
Learning Zone homepage
Biosimilars in retinal disease Learning Zone
132 mins
Diagnosing glaucoma
Learning Zone
Glaucoma Learning Zone
190 mins
Anti TNF Antibody teaser tile
Learning Zone Homepage
Anti-TNF biosimilars for rheumatic diseases
120 mins
CAT_Thrombosis
Learning Zone
Venous Thromboembolism (VTE) Learning Zone
350 mins
Anti-platelet hero
Learning Zone Homepage
Antiplatelet therapy in ACS: Choices and Controversies
270 mins
Anticoagulation therapy for stroke prevention
Learning Zone Homepage
Anticoagulation Therapy for Stroke Prevention
300 mins
RSV virus teaser image
Learning Zone Homepage
Respiratory Syncytial Virus (RSV) in Adults
180 mins
patient receiving dialysis, hospital image
Learning Zone Homepage
Chronic Kidney Disease Learning Zone
340 mins
RET Inhibition
Learning Zone Homepage
Molecular diagnostics for RET inhibition in NSCLC and thyroid cancers
270 mins
Homepage_HS_Patient and doctor speaking_ Teaser image
Learning Zone Homepage
Hidradenitis suppurativa (HS) Learning Zone
200 mins
Chronic Spontaneous Urticaria
Learning Zone Homepage
Chronic Spontaneous Urticaria Learning Zone
1135 mins
Brain nerve cells
Learning Zone Homepage
Multiple Sclerosis (MS) Learning Zone
160 mins
Food Allergy_Selection of foods and allergies TEASER
Learning Zone Homepage
Food Allergy Learning Zone
220 mins
Cardiovascular Metabolism
Learning Zone
Cardiovascular Metabolism Learning Zone
380 mins
Woman with gut pain
Learning Zone
Inflammatory Bowel Disease Learning Zone
100 mins
surgery
Learning Zone Homepage
Transplantation Learning Zone
730 mins
Primary Hyperoxaluria Type 1
Learning Zone
Diagnosis and management of primary hyperoxaluria type 1
110 mins
PaedDerma_Girl and Doctor TEASER image
Learning Zone Homepage
Improving treatment options for childhood psoriasis
270 mins
Managing risk of recurrence in early breast cancer – what’s on the horizon?
Learning Zone
CDK4/6 inhibitors in breast cancer
190 mins
Osteoarthritis
Learning Zone Homepage
Managing Osteoarthritis-associated Pain
265 mins
Respiratory Care
Learning Zone Homepage
Respiratory Care
530 mins
Biosimilars
Learning Zone Homepage
Optimising anti-TNF treatment using biosimilars
100 mins
Fibrinogen Deficiency
Learning Zone Homepage
Fibrinogen Deficiency in Bleeding Learning Zone
160 mins
ipf-hero_teaser
Learning Zone Homepage
Idiopathic Pulmonary Fibrosis
140 mins
Oral Anticoagulation Reversal TEASER image
Learning Zone Homepage
Oral Anticoagulation Reversal Learning Zone
355 mins
Plaque psoriasis
Learning Zone Homepage
Psoriasis Academy
910 mins
Neuroscience and Pain
Learning Zone Homepage
One Neuroscience and Pain Learning Zone
830 mins

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.